GratXray will be presenting at the MedTech Strategist Innovation Summit in Dublin from April 28–30, 2026. The conference is one of Europe’s leading partnering and investment events for emerging medical technology companies, bringing together innovative startups, investors, and strategic partners from around the world. At the summit, CEO and Co-Founder Martin Stauber will present senoa, […]
GratXray AG is pleased to announce the inauguration of its new development laboratory at the Healthtechpark Schlieren-Zurich. This milestone marks an important step forward in the company’s mission to make reliable breast cancer detection accessible to all women. The expanded facilities will enable GratXray to accelerate the development of its senoa™ breast-CT system.
GratXray AG will participate in the DeepTech Investor Summit 2026 on January 26-27 at ETH Zurich. The event brings together leading venture capitalists, corporate investors, and family offices with over 100 cutting-edge deep tech spin-offs from the ETH domain. As a PSI and ETH Zurich spin-off, GratXray will present senoa, its revolutionary pain-free 3D breast […]
GratXray AG is excited to announce its participation at the Radiological Society of North America (RSNA) 2025 Annual Meeting, taking place November 30 to December 4 at McCormick Place in Chicago. At booth 8209 in North Hall, GratXray will showcase its senoa breast CT scanner, demonstrating how the technology is transforming breast imaging through pain […]
GratXray AG is pleased to announce the launch of its redesigned website, providing comprehensive information about the company’s innovative senoa breast CT technology and vision for transforming breast cancer diagnostics. The new website reflects GratXray’s patient centered approach, showcasing how senoa’s pain free 3D imaging technology prioritizes women’s comfort and well being throughout the diagnostic […]
